ArticleScientific reports2023

Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting.

Yaniss Belaroussi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.